| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/10/2011 | CN102145175A Sorafenib tosylate-hydroxypropyl-beta-cyclodextrin clathrate compound and preparation method thereof |
| 08/10/2011 | CN102145174A Chondroitin sulfate nano-selenium and preparation method thereof |
| 08/10/2011 | CN102145173A Human serum albumin complex hydrophobically modified pullulan nanoparticles and preparation method thereof |
| 08/10/2011 | CN102145170A Sensitizer for radiotherapy and chemotherapy of malignant tumor |
| 08/10/2011 | CN102145161A Application of integrin blocking agent in preparing medicament for treating tumors |
| 08/10/2011 | CN102145160A Controlled-release implanting preparation used for injecting LHRH (luteinizing hormone releasing hormone) antagonist |
| 08/10/2011 | CN102145159A Ginger and elecampane composition, preparation method of ginger and elecampane composition and use of ginger and elecampane composition for preparing toxicity-reducing efficacy-improving medicine in cancer radiotherapy and chemotherapy |
| 08/10/2011 | CN102145158A Ginger and clove composition, preparation method of ginger and clove composition and use of ginger and clove composition for preparing toxicity-reducing efficacy-improving medicine in cancer radiotherapy and chemotherapy |
| 08/10/2011 | CN102145151A Chinese medicinal herb composition for treating cancers |
| 08/10/2011 | CN102145135A Process for extracting bamboo leaf coarse polysaccharide by supercritical CO2 fluid extraction technology |
| 08/10/2011 | CN102145071A Medicinal compositions for inhibiting growth of stem cells |
| 08/10/2011 | CN102145062A Active extracts of rosa roxburghii tratt fruit, and preparation method, detection method and application thereof |
| 08/10/2011 | CN102145030A Kiwi soft capsule preparation method with functions of regulating immunity and inhibiting tumors |
| 08/10/2011 | CN102145029A Lycopene-containing tablets and preparation method thereof |
| 08/10/2011 | CN102144990A Perfluorocarbon liquids as carcinogen |
| 08/10/2011 | CN102144981A Gemcitabine hydrochloride lyophilized powder injection and preparation method thereof |
| 08/10/2011 | CN102144980A LHRH (luteinizing hormone-releasing hormone antagonist) lyophilized powder injection with improved stability |
| 08/10/2011 | CN102144979A frozen powder preparation for injection of L-gossypol or acetate of L-gossypol for treatment of tumor |
| 08/10/2011 | CN102144973A Prescription composition of optimized siRNA cation liposome |
| 08/10/2011 | CN102144969A Method for preparing etoposide nanometer suspension freeze-drying preparation |
| 08/10/2011 | CN101974068B Tanshinon IIA crylic acid or sodium salt thereof, preparation method and application thereof |
| 08/10/2011 | CN101732522B Plaster for treating osteonecrosis of the femoral head, osseous tuberculosis, osteomyelitis and osteoma |
| 08/10/2011 | CN101721397B Medical application of 6-shogaol for treating cervical cancer, leukemia and breast cancer |
| 08/10/2011 | CN101711829B Dripping pill for treating mammary cancer |
| 08/10/2011 | CN101708337B Preparation method of human serum albumin nano granules coated with oxaliplatin |
| 08/10/2011 | CN101708193B Pharmaceutical composition of triptolide-containing medicine and bracken and preparation and application thereof |
| 08/10/2011 | CN101700227B Matrine colon targeted adhesive pellet and preparation method thereof |
| 08/10/2011 | CN101697972B Application of neoaspergillic acid in preparing antitumor drugs |
| 08/10/2011 | CN101669925B Dry powder inhalation, preparation method and application thereof |
| 08/10/2011 | CN101648993B Small peptide A with antibacterial and antitumor functions and applications thereof |
| 08/10/2011 | CN101619063B 3,7,8-polysubstituted pyridine-[4,3-d] pyrimidine derivant with antitumor activity and preparation |
| 08/10/2011 | CN101612281B Traditional Chinese medicine for treating mammary cancer and stomach cancer |
| 08/10/2011 | CN101591314B Ophiobolin di-sesquiterpene compound and preparation method and application thereof |
| 08/10/2011 | CN101544634B 2-phenyl-3-substituted pyrazolo[1,5-a]pyridine derivatives, preparation method and application thereof |
| 08/10/2011 | CN101514230B Monoclone antibody of ARD1 and application thereof |
| 08/10/2011 | CN101502545B Method for preparing Chinese medicine for resisting cancer and treating cancer ache |
| 08/10/2011 | CN101481412B Polypeptide with antineoplastic function, encoding gene and use thereof |
| 08/10/2011 | CN101433692B Effective component of turmeric rhizome and preparation method and use thereof |
| 08/10/2011 | CN101429158B 2,4-diketone quinoline alkaloid, preparation and uses thereof |
| 08/10/2011 | CN101367850B Norabieta cantharidin derivant and synthesis thereof |
| 08/10/2011 | CN101351466B Heterocyclic Janus kinase 3 inhibitors |
| 08/10/2011 | CN101347500B Effective component of rabdosia and preparation and use thereof |
| 08/10/2011 | CN101347475B Use of Alstonia mairei extract in preparing anti-tumor medicament |
| 08/10/2011 | CN101340914B Reduction of side effects from aromatase inhibitors used for treating breast cancer |
| 08/10/2011 | CN101199344B Integrated technology of asparagus' all-nutrient substance |
| 08/10/2011 | CN101061860B Leucine-rich nutritional compositions |
| 08/10/2011 | CN101011499B Linaloe leaf extract, pharmaceutical and health care uses thereof |
| 08/09/2011 | US7994346 such as methyl 2-({(4S,5R)-5-[(1E,3E,7E)-(S)-10-(4-fluorophenoxy)-9-hydroxydeca-1,3,7-trien-5-yn-1-yl]-2,2-dimethyl-1,3-dioxolan-4-yl}methoxy)acetate, useful in treating inflammatory and autoimmune disorders in humans |
| 08/09/2011 | US7994332 Process for producing crystal |
| 08/09/2011 | US7994318 Coumarin derivatives useful as TNFα inhibitors |
| 08/09/2011 | US7994309 double-stranded ribonucleic acid (dsRNA); degradation of the mRNA transcript of the bcl-2 gene, thereby inhibiting expression of the target gene in the cell; anticarcinogenic agent |
| 08/09/2011 | US7994294 Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase |
| 08/09/2011 | US7994292 MU-1, member of the cytokine receptor family |
| 08/09/2011 | US7994289 Humanized anti-CD3 antibodies |
| 08/09/2011 | US7994282 Card proteins involved in cell death regulation |
| 08/09/2011 | US7994276 Composition of tumour-associated peptides and related anti-cancer vaccine |
| 08/09/2011 | US7994212 For therapy of of neoplastic diseases |
| 08/09/2011 | US7994208 Crystalline chemotherapeutic |
| 08/09/2011 | US7994198 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 08/09/2011 | US7994196 Indazole compound and pharmaceutical use thereof |
| 08/09/2011 | US7994180 Processes for preparing intermediates of pemetrexed |
| 08/09/2011 | US7994172 [1H-pyrazolo[3, 4-D]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (P70s6k, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases |
| 08/09/2011 | US7994159 inhibits proliferation of c-Kit kinase activated-cancer; also mastocytosis, allergy and asthma, which are considered to be caused by c-Kit kinase; 4-(3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide |
| 08/09/2011 | US7994152 Method of treating a cancer by administering A 2′,5′-oligoadenylate analog |
| 08/09/2011 | US7994146 Method of enhancing an immune response |
| 08/09/2011 | US7994134 Peptide-based compounds |
| 08/09/2011 | US7993849 Human TIMP-1 antibodies |
| 08/09/2011 | US7993834 Detection of ErbB2 gene amplification to increase the likelihood of the effectiveness of ErbB2 antibody breast cancer therapy |
| 08/09/2011 | US7993829 HPRP4s modifiers of the p53 pathway and methods of use |
| 08/09/2011 | US7993678 Hyaluronic acid derivatives |
| 08/09/2011 | US7993650 Polypeptides having binding affinity for HER2 |
| 08/09/2011 | US7993644 Tissue factor antibodies and uses thereof |
| 08/09/2011 | US7993641 Methods of treatment using anti-CD3 antibodies |
| 08/09/2011 | CA2617991C N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof |
| 08/09/2011 | CA2552050C Substituted heterocycles and the uses thereof |
| 08/09/2011 | CA2529507C Compounds and methods for inducing apoptosis in cancer cells |
| 08/09/2011 | CA2526943C Compositions comprising hepoxilin analogs and their use in the treatment of cancer |
| 08/09/2011 | CA2514227C Combination therapy of zd6474 with 5-fu or/and cpt-11 |
| 08/09/2011 | CA2512000C Selective estrogen receptor modulator |
| 08/09/2011 | CA2450179C Identification of stat6 modulators using ncoa-1/stat6 interaction |
| 08/09/2011 | CA2447921C Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 08/09/2011 | CA2441492C Rho-kinase inhibitors |
| 08/09/2011 | CA2438092C Ttk in diagnosis and as a therapeutic target in cancer |
| 08/09/2011 | CA2432568C Benzoylpyridazines |
| 08/09/2011 | CA2431842C Method for preparing tryptophan rich peptides |
| 08/09/2011 | CA2367360C Insulin-like growth factor binding protein-4 protease |
| 08/09/2011 | CA2243559C Pharmaceutical composition for immunomodulation |
| 08/04/2011 | WO2011094708A2 Small molecules for the modulation of mcl-1 and methods of modulatiing cell death, cell division, cell differentiation and methods of treating disorders |
| 08/04/2011 | WO2011094671A2 N-terminally conjugated polypeptides for targeted therapy and diagnosis |
| 08/04/2011 | WO2011094431A1 Sustained-release nsaid/hmg coa reductase inhibitor compositions |
| 08/04/2011 | WO2011094426A1 Caspase inhibitors |
| 08/04/2011 | WO2011094389A2 Cxcr4 antagonists for imaging of cancer and inflammatory disorders |
| 08/04/2011 | WO2011094335A2 Microrna signatures predicting responsiveness to anti-her2 therapy |
| 08/04/2011 | WO2011094283A1 Pyrazolopyridine kinase inhibitors |
| 08/04/2011 | WO2011094273A1 Pyrazolopyridine kinase inhibitors |
| 08/04/2011 | WO2011094260A2 Novel bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer |
| 08/04/2011 | WO2011093684A2 THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY ON PROTEIN KINASES |
| 08/04/2011 | WO2011093559A1 Composition for the prevention or treatment of gastric cancer containing ursodeoxycholic acid as an active ingredient |
| 08/04/2011 | WO2011093524A1 Di - substituted pyridine derivatives as anticancers |
| 08/04/2011 | WO2011093468A1 Transformation plasmid |